drugset / Trial / NCT02422446

Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects

NCT02422446

Phase 3 Terminated 2 enrolled Brigham and Women's Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

This pilot trial seeks to obtain preliminary data on the effects of eicosapentaenoic acid (EPA) (4g/d) on endothelial function measured via endopat2000 after 12 weeks of intervention among adults with elevated triglycerides and type 2 diabetes.

Timeline

Start
2015-04
Primary completion
2017-03-01
Completion
2017-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject icosapent ethyl Small molecule 4 g